Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

GW406108X(Z/E)

Catalog No. T9207L Copy Product Info
Purity: 98.23%
😃Good
GW406108X(Z/E) is a mixture of different configurations of GW406108X, which is an inhibitor of Kinesin-12 and ULK1 .

GW406108X(Z/E)

Copy Product Info
😃Good
Catalog No. T9207L

GW406108X(Z/E) is a mixture of different configurations of GW406108X, which is an inhibitor of Kinesin-12 and ULK1 .

GW406108X(Z/E)
Cas No. 265098-01-9
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$133In StockIn Stock
5 mg$302In StockIn Stock
10 mg$453In StockIn Stock
25 mg$680In StockIn Stock
50 mg$1,020In StockIn Stock
100 mg$1,370In StockIn Stock
1 mL x 10 mM (in DMSO)$297In StockIn Stock
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.23%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

GW406108X(Z/E) AI Summary
GW406108X(Z/E) exhibits significant bioactivities, including the inhibition of cRaf1 kinase with an IC50 value of 46.0 nM and a 94.0% inhibition of EGF-stimulated MAP kinase activation at a concentration of 15 µM, without affecting EGFR phosphorylation. It also demonstrates moderate inhibition of IKK-alpha and IKK-beta and a high level of inhibition for IKK-epsilon at 1 µM concentration. Additionally, it shows strong inhibition of PIP5K1 at 5 µM concentration and considerable inhibition of TBK1 at 1 µM concentration. The compound exhibits variable effects on cell viability in different cell lines, suggesting cell-type-specific responses. In thermal shift assays, GW406108X(Z/E) significantly increases thermal stability for several protein domains (ΔTm values from 0.54°C to 5.93°C) but decreases stability (ΔTm = -3.45°C) for the G861-E979 domain, indicating potential binding and stabilization effects on these regions. The compound also inhibits Sea Pansy Luciferase with an AC50 of 16343.2 nM and Firefly Luciferase with an AC50 of 18337.4 nM..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
GW406108X(Z/E) is a mixture of different configurations of GW406108X, which is an inhibitor of Kinesin-12 and ULK1 .
Chemical Properties
Molecular Weight400.21
FormulaC20H11Cl2NO4
Cas No.265098-01-9
SmilesC(=C1C=2C(NC1=O)=CC=C(C(=O)C3=CC=CO3)C2)C4=CC(Cl)=C(O)C(Cl)=C4
Relative Density.1.527 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 30 mg/mL (74.96 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4987 mL12.4934 mL24.9869 mL124.9344 mL
5 mM0.4997 mL2.4987 mL4.9974 mL24.9869 mL
10 mM0.2499 mL1.2493 mL2.4987 mL12.4934 mL
20 mM0.1249 mL0.6247 mL1.2493 mL6.2467 mL
50 mM0.0500 mL0.2499 mL0.4997 mL2.4987 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GW406108X(Z/E) | purchase GW406108X(Z/E) | GW406108X(Z/E) cost | order GW406108X(Z/E) | GW406108X(Z/E) chemical structure | GW406108X(Z/E) formula | GW406108X(Z/E) molecular weight